Healthcare Global Enterprises Ltd (HCG) โ Board Meeting | 27 August 2026
The 28th Annual General Meeting of Healthcare Global Enterprises Ltd (HCG) was held on August 27, 2026, for FY 2025-26. Key resolutions included approval of the consultancy agreement extension with Anjali Ajaikumar (INR 1.50 crore annual fee for 6 months), ratification of cost auditor remuneration (INR 2.50 lakh), and re-appointments of directors Simrun Mehta and Akshay Tanna. The meeting addressed share capital increases via employee stock option exercises and a rights issue, resulting in a 95% equity proportion. Financial highlights showed 15% revenue growth to INR 25,384.29 million, improved EBITDA margin (18.30%), and strong cash generation. The company emphasized expansion in oncology infrastructure, including new facilities in Hebbal and Vizag, and strategic acquisitions to address India's growing cancer care demand (projected to reach 35 million cases by 2050).
About Healthcare Global Enterprises Ltd (HCG)
Healthcare ยท Healthcare ยท Listed on BSE
๐ก Get AI alerts when HCG files next
Free โข Daily 5 PM digest โข Track filings, board meetings, and corporate actions
Track HCG โ Free๐ก Ask AI about this filing
๐ More HCG filings
- Announcement โ 30 September 2026HealthCare Global Enterprises Ltd announced that its trading window will close on October 1, 2026, f...
- ๐ก Voting Results โ 18 September 2026HealthCare Global Enterprises Limited held its 28th Annual General Meeting on September 18, 2026, vi...
- ๐ก Board Meeting โ 18 September 2026HealthCare Global Enterprises held its 28th AGM on September 18, 2026, via video conferencing, with ...
- ๐ด Announcement โ 17 September 2026HealthCare Global Enterprises announced an investor meeting on September 22, 2026, in Mumbai with Pr...
- ๐ด Announcement โ 16 September 2026HealthCare Global Enterprises Limited announced its schedule for an analyst and institutional invest...
๐ฅ Also filed on 27 August 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only โ not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
๐ก Get AI alerts when HCG files new disclosures
Track HCG filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track HCG โ FreeFree account ยท 2 AI queries/day